CORRECTION article

Front. Immunol., 12 August 2025

Sec. Cancer Immunity and Immunotherapy

Volume 16 - 2025 | https://doi.org/10.3389/fimmu.2025.1670563

Correction: Identification of prognosis and therapy related intratumoral microbiome and immune signatures in gastric cancer

  • 1. Department of Gastric Surgery, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Key Laboratory of Digestive Cancer, Tianjin’s Clinical Research Center for Cancer, Tianjin, China

  • 2. Department of Emergency Ward, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, China

  • 3. Department of Gastrointestinal Cancer Biology, Tianjin Medical University Cancer Institute and Hospital, Key Laboratory of Cancer Immunology and Biotherapy, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China

  • 4. Department of Endoscopy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin, China

  • 5. Department of Pancreatic Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin Key Laboratory of Digestive Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China

In the published article, there was an error in the Funding statement. The funder “Tianjin Key Medical Discipline (Specialty) Construction Project, TJYXZDXK-009A” was erroneously omitted. The correct Funding statement appears below.

“The author(s) declare that financial support was received for the research and/or publication of this article. This work was supported by grants from the Tianjin Key Medical Discipline (Specialty) Construction Project (TJYXZDXK-009A), Introduction of Talents and Doctoral Startup Fund (B2301 and B2320), The China Postdoctoral Science Foundation (2023M742618) and China National Postdoctoral Program for Innovative Talent (BX20240254).”

The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

gastric cancer, intratumoral microbiome, prognostic biomarkers, therapeutic responses, drug sensitivity, comprehensive analysis

Citation

Jin P, Ji X, Bai J, Su W, Ke B, Liu Y and Wang B (2025) Correction: Identification of prognosis and therapy related intratumoral microbiome and immune signatures in gastric cancer. Front. Immunol. 16:1670563. doi: 10.3389/fimmu.2025.1670563

Received

21 July 2025

Accepted

31 July 2025

Published

12 August 2025

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

16 - 2025

Updates

Copyright

*Correspondence: Bin Wang,

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics